

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+3.92%
+23.22%
+5.47%
RNA
Avidity Biosciences
$69.93
Strengths

Upgraded on attractively valued
Chart
$42.63 (+64.04%)
$35.92 (+94.68%)
$34.22 (+104.35%)
$47.51 (+47.19%)
RNA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

RNA overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
RNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RNA Street view is not attractive and have negative views on the near-term outlook
Average key support and resistance price levels.
Login to displayRNA Earnings
The TTM reflects 12-month period, providing review of RNA financial performance.
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
What is RNA current stock price?
What are RNA stock strengths?
What risks are associated with RNA stock?
When is RNA next earnings report?
What is RNA market cap and volume?
What is RNA's current Stock IQ?
Should I buy RNA stock right now?
Is RNA a Strong Buy right now?
What does a 'Strong Buy' rating mean for RNA?
What does a 'Strong Sell' rating mean for RNA?
What factors influence RNA's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+3.92%
+23.22%
+5.47%
RNA
Avidity Biosciences
Current Price
$69.93
Stock Insights
Strengths

Upgraded on attractively valued
Chart
$42.63 (+64.04%)
$35.92 (+94.68%)
$34.22 (+104.35%)
$47.51 (+47.19%)
RNA Analysts Opinion
RNA Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future
![]()
RNA Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
RNA Street view is not attractive and have negative views on the near-term outlook
RNA has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk

Average key support and resistance price levels.
RNA Earnings
The TTM data reflects the most recent 12-month period, providing overview of RNA financial performance.
RNA Financial Health
The company financial health is gradually deteriorating, indicating rising risks and weakening fundamentals
Financial Score
RNA Latest Analysis
RNA Crosses Above Average Analyst Target. In recent trading shares of Avidity Biosciences Inc (Symbol: RNA) have crossed above the average analyst 12-month target price of $68.31 changing hands for $70.00/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade
Today
Why Avidity Biosciences Stock Blasted 42% Higher Today. Key PointsIt is being acquired for quite a meaty premium.
Mon Oct 27, 2025
Notable Monday Option Activity: RNA HUN BCO. Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Avidity Biosciences Inc (Symbol: RNA) where a total volume of 23392 contracts has been traded thus far today a contract volume which is representative of appr
Mon Oct 27, 2025
Why Avidity Biosciences Shares Are Trading Higher By Around 42%. Here Are 20 Stocks Moving Premarket. Shares of RNA) rose sharply in pre-market trading after the company agreed to be acquired by NVS).Holders of Avidity common stock will receive $72.00 per share in cash at closing representing a premium of around 46% over Avidity’.s closing share price on Oct. 24.Avidity Biosciences shares surged 42.1% to $69.85 in the pre-market trading session.Here are some other stocks moving in pre-marke
Mon Oct 27, 2025
Avidity Biosciences delays DMD drug submission to Q1 2026.
Mon Oct 13, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.